Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 and further to letter No. SPARC/Sec/SE/2019-20/027 dated 20th August 2019, Sun Pharma Advanced Research Company has informed that, Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against SPARC regarding SPARCs New Drug Application for PICS (Paclitaxel Injection Concentrate for Suspension).
The above information is a part of company’s filings submitted to BSE.